Russ Swan, Editor, writes:
We see from your search that you're looking for information on the term "Cancer Research",
and we have a large number of manufacturers' news releases and technical articles here on Laboratorytalk which will be of interest.
Let me be your guide.
Start with
the news release Speaker programme announced for 2008 ICR meeting from
ICR (Institute of Clinical Research), which we summarised at the time by saying "The Institute of Clinical Research (ICR) has announced the speaker programme for its forthcoming annual spring conference and exhibition - the largest clinical research
event of its kind in Europe".
A couple of weeks before,
we featured the news release Genomic Grade to improve breast cancer diagnosis from
Ipsogen: "Ipsogen has announced the signature of a license agreement with Universite Libre de Bruxelles (ULB), Belgium for the worldwide and exclusive rights on the Genomic Grade".
In January 2008, we covered the news from Cancer Research UK
- take a look at CRT licenses antibody technology to Glycart
which says: "Specialist oncology-focused development and commercialisation company has granted an exclusive worldwide licence to Glycart Biotechnology to develop a preclinical antibody for the treatment of cancer".
Take a look also at the news release from Nikon UK, Cellular imaging centre opens at Curie Institute,
as well as Early registration deadline for IHC meeting from Euroscicon,
and Control of hypoxic conditions in cancer research from Don Whitley Scientific.
See also:
New molecular markers for testicular cancer
(October 2007)
Researchers in the Netherlands use new technology from Applied Biosystems to identify different expression patterns of microRNA molecules in normal and cancerous cells
Funding doubles in cancer research
(September 2007)
Cancer Research UK funded a record £315m of research last year, marking a near doubling in research funding since the charity was formed five years ago
Novozymes, UCL, and CRT conclude collaboration
(September 2007)
The collaboration will generate anti-CEA scFv molecules which will be genetically fused with albumin using Novozymes proprietary Albufuse technology for future therapeutic or preventive applications
Supercomputer shines light on cancer research
(September 2007)
Diamond Light Source, the new UK synchrotron, uses a high performance computer from OCF to accelerate analysis times in the quest for speedier drug discovery
FFPE kit for Oligo CGH microarrays is unveiled
(August 2007)
Labelling kits that, for the first time, enable oligo microarray comparative genomic hybridisation (CGH) analysis of DNA from formalin-fixed paraffin-embedded (FFPE) tissue samples have been unveiled
Tecan workstations help automate cancer research
(August 2007)
Researchers at the life sciences company Genomic Health, California, USA, have chosen Tecan's liquid handling workstations to automate the development of Genomic's multi-gene expression assay
HPLC/Chip MS used to develop protein database
(August 2007)
Database developed using Agilent Technologies's HPLC-Chip/mass spectrometry (MS) system will aid researchers in efforts to identify proteins and discover biomarkers associated with types of cancer
Digital pathology for tissue microarray analysis
(July 2007)
Aperio Technologies has launched TMALab II, the latest release of its web-based digital pathology information management system, built specifically for researchers who use tissue microarrays (TMAs)
Research collaboration in tumour imaging
(July 2007)
The three-year research collaboration will be funded by AstraZeneca and focus on the development of cutting-edge real-time fluorescence and confocal imaging techniques
NCE Discovery and Domainex merge
(July 2007)
Domainex and NCE Discovery have merged to form a new drug discovery company focused on nucleotide triphosphate (NTP)-dependent proteins
First CGH microarrays optimised for FFPE samples
(July 2007)
Agilent has licensed labelling technology from Kreatech to optimise array-based comparative genomic hybridisation (aCGH) platform for DNA from formalin-fixed paraffin-embedded (FFPE) tissue samples
SmartScan answers storage issues at biobank
(July 2007)
Thermo has supplied Oncore UK, a collaboration by the UK's largest governmental and nongovernmental agencies in the fight against cancer, with specimen storage in the first UK national cancer biobank
Scientist wins award for cancer diagnostic markers
(June 2007)
MCM proteins found to have potential as the basis of simple non-invasive tests for a range of cancers, including cervical, bladder, colorectal, lung, and cancer of the oesophagus
License fees support institute and patient care
(June 2007)
Roswell Park Cancer Institute (RPCI) reports that quarterly royalty payments for its RPCI-BAC-11 library have doubled for the fourth consecutive quarter under a licensing agreement with BlueGnome
Science policy should have more community emphasis
(May 2007)
Science policy analysts Sheila Jasanhoff (Kennedy school of government, Harvard) and Suzan Cozzens (Georgia Institute of Technology) urge a fundamental shift in the way scientific research is done
Live auction in support of charity
(May 2007)
This year, GenoLogics is actively supporting the Canary Derby by building a soapbox car and organising fundraising activities over the past three months
Cancer Research Technology laboratories to expand
(May 2007)
The development laboratories, working on an industrial model in collaboration with the originating academics, will double in size with the number of scientists increasing from about 45 to 90
Genes affect prognosis of colon cancer patients
(May 2007)
Research at French National Institute of Health and Medical Research (Inserm) suggests that a patient's own immune response may be more important than the tumor type in determining disease prognosis
CRT licenses therapeutic antibodies to Peptech
(May 2007)
Cancer Research Technology (CRT), the oncology-focused development and commercialisation company, has licensed rights to a panel of cancer therapeutic antibodies to Peptech
Proceedings of immunohistochemistry meeting
(May 2007)
With over 200 delegates, EuroSciCon's Improving Immunohistochemistry meeting on 20 April 2007 is growing in popularity and once again was a great success, it says
Probing tissue morphology in biological specimens
(April 2007)
Michelson Diagnostics has announced the EX1301 OCT microscope, which provides high-resolution sub-surface images from much deeper into the sample than is possible with conventional microscopes
Peptide synthesiser stars at German symposium
(April 2007)
Activotec selected the recent 8th German Peptide Symposium in Heidelberg, Germany, to display its latest products and proprietary techniques for peptide synthesis
Pioneering cancer expert appointed chief scientist
(April 2007)
Cancer Research UK has appointed world-leading cancer researcher Professor Sir David Lane as its first chief scientist
Cancer centre uses Nikon confocal and PFS systems
(April 2007)
The Cancer Research UK Cambridge Research Institute (CRI) is a state-of-the-art imaging centre, featuring confocal systems and TE2000 perfect focus systems (PFS) supplied by Nikon Instruments UK
New CEO to spearhead CRT laboratory expansion
(April 2007)
Keith Blundy, 46, joined CRT - Cancer Research UK's development and commercialisation company - in 1998 and has been the company's chief operating officer since November 2003
Astell equips new Henry Wellcome building
(March 2007)
To meet the Gurdon Institute's exacting requirements it has installed three 500 litre and two 350 litre Astell Logicolor square section sterilisers
pDG helper, packaging vectors for AAV production
(March 2007)
Vectors such as pDG, pDM, pDP1rs to pDP6rs and pDG without a heparin binding motive are immediately available from PlasmidFactory
Major new cancer research initiative opens in UK
(February 2007)
Lancer 1400 series lab glassware washers and dryers have been installed at the new Cancer Research UK Cambridge Research Institute opened by Queen Elizabeth this month
Australian cooperation in cancer therapy
(January 2007)
Seven of Australia's leading research organisations plus Cancer Research Technology, Bionomics, and Millipore/Chemicon, are forming the Cooperative Research Centre for Cancer Therapeutics (CRC-CT)
Walter Wenninger appointed to Santaris board
(January 2007)
Santaris Pharma, the Danish biopharmaceutical company focussed on RNAi medicines, announces that Walter Wenninger has been elected a member of the board of directors
VTT and Bayer Schering start research project
(January 2007)
VTT has signed a two year contract on research collaboration with Bayer Schering Pharma regarding the studies on the mode of action of a new cancer drug
Roche launches second generation 454 sequencer
(January 2007)
System builds on the Roche Applied Science's and 454 Life Sciences's joint commitment to innovation in high-throughput sequencing through the provision of longer read lengths and enhanced throughput
Milestone payment for Vernalis's Hsp90 programme
(December 2006)
CRT and Institute of Cancer Research are to receive a milestone payment from Vernalis following the selection of a second preclinical development candidate by Novartis in its Hsp90 drug programme
Clinical pharmacology collaboration in oncology
(November 2006)
Cancer Research Technology and the University of Manchester announce a clinical pharmacology collaboration in oncology with AstraZeneca